Obesity surgeries are often called bariatric surgeries, which make use of a variety of obesity surgery devices.
Increasing prevalence of obesity among children as well as adults all over the globe has become a serious health issue. This will remain a key factor fueling the demand for obesity surgery devices in the global market. Growing inclination toward sedentary lifestyle and burgeoning frequency of consuming junk food are the most likely to boost obesity, and eventually the market for obesity surgery devices.
North America has been the largest market for obesity surgery devices, followed by Europe.

The global Obesity Surgery Device market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Obesity Surgery Device volume and value at global level, regional level and company level. From a global perspective, this report represents overall Obesity Surgery Device market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Obesity Surgery Device in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Obesity Surgery Device manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Johnson & Johnson
Medtronic
Apollo Endosurgery
Covidien
Mediflex Surgical Product
Aspire Bariatrics
Spatz FGIA
MetaCure
IntraPace
TransEnterix

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Intragastric Balloons
Gastric Electrical Stimulation
Gastric Bands
Others

Segment by Application
Hospitals
Clinics
Others